Eyeing Terrorist Potential, Pentagon Seeks Vaccine Against Cold War-Era Bioweapon

"Q-fever" bacteria are seen through a laboratory microscope as they grow inside a biological cell. The U.S. Defense Department plans next week to lead a discussion with potential developers of a new vaccine against the possible bioterrorism agent.
National Journal
Diane Barnes, Global Security Newswire
Add to Briefcase
See more stories about...
Diane Barnes, Global Security Newswire
Nov. 27, 2013, 10:02 a.m.

WASH­ING­TON — The U.S. De­fense De­part­ment is get­ting set to push for a new vac­cine against “Q-fever” bac­teria, an agent with a repu­ta­tion as a po­ten­tial ter­ror­ism tool ac­quired in part through its his­tory as a gov­ern­ment-made bio­lo­gic­al weapon.

The Pentagon’s De­fense Threat Re­duc­tion Agency is plan­ning an on­line for­um on Dec. 5 to fa­cil­it­ate con­ver­sa­tion with po­ten­tial de­velopers of a vac­cine against Q fever, which is also known by the bac­teria’s form­al des­ig­na­tion, Cox­i­ella bur­netii.

The United States in­vest­ig­ated the agent’s war­fare po­ten­tial and the So­viet Uni­on fully weapon­ized it dec­ades ago, long be­fore both coun­tries form­ally de­nounced bio­lo­gic­al arms in the 1970s. The dis­ease also oc­curs in nature and has af­fected hun­dreds of U.S. troops de­ployed over­seas.

It can pro­duce fever, pneu­mo­nia, and nu­mer­ous oth­er symp­toms as­so­ci­ated with a vari­ety of patho­gens.

Cer­tain an­ti­bi­ot­ics are con­sidered ef­fect­ive against the bac­teria, but no vac­cine is presently sold in the United States, ac­cord­ing to the Fed­er­a­tion of Amer­ic­an Sci­ent­ists. An ex­ist­ing vac­cin­a­tion avail­able abroad re­portedly can cause side ef­fects such as abs­cesses and swollen joints.

The United States “should def­in­itely have a Q fever vac­cine,” Amesh Adalja, a seni­or as­so­ci­ate with the Cen­ter for Health Se­cur­ity at the Uni­versity of Pitt­s­burgh Med­ic­al Cen­ter, said in a phone in­ter­view. “This is still a dis­ease that has some pub­lic health bur­den, in ad­di­tion to its po­ten­tial use as a bioweapon.”

The U.S.-led oc­cu­pa­tion of Ir­aq led to roughly 200 “acute” Q-fever cases among U.S. sol­diers, the Cen­ters for Dis­ease Con­trol and Pre­ven­tion re­por­ted earli­er this year.

Those in­fec­tions ap­peared to res­ult from un­in­ten­tion­al ex­pos­ure to an­im­al car­ri­ers or bac­teria swept up by heli­copter ro­tors. Such nat­ur­ally oc­cur­ring cases rarely cause death, but Adalja sug­ges­ted the agent could prove more dan­ger­ous if in­cor­por­ated in a weapon.

Q-Fever bac­teria in­fec­ted but re­portedly did not kill any con­scien­tious war ob­ject­ors de­lib­er­ately ex­posed to the agent dur­ing U.S. Army ex­per­i­ments in the 1950s.

The United States has been eye­ing a new Q-fever vac­cine for sev­er­al years. However, the agent’s status as a po­ten­tial bi­o­ter­ror­ism tool is fairly new, re­l­at­ive to how long it has been an es­tab­lished bio­lo­gic­al weapon. CDC of­fi­cials only began track­ing Q-fever in­fec­tions in 1999, as the Clin­ton ad­min­is­tra­tion was in­creas­ing the na­tion’s fo­cus on bio­lo­gic­al ter­ror­ism as a na­tion­al-se­cur­ity threat.

A CDC list of po­ten­tial bi­o­ter­ror­ism agents and dis­eases, which in­cludes Q fever, “is de­rived al­most solely from the U.S. and So­viet bioweapons pro­grams,” Adalja said. He sug­ges­ted that the U.S. gov­ern­ment is “sub­stan­tially” more likely to fund de­vel­op­ment of vac­cines and treat­ments for such agents than for patho­gens nev­er in­volved in gov­ern­ment bio­lo­gic­al-weapons pro­grams.

Agents more than dan­ger­ous than Q-fever may have emerged since the Cold-War height of the U.S. and So­viet bio­lo­gic­al-weapons pro­grams, but the es­tab­lished track re­cord of his­tor­ic­al bio­lo­gic­al arms could make them par­tic­u­larly at­tract­ive to would-be bi­o­ter­ror­ists, Adalja said.

This art­icle was pub­lished in Glob­al Se­cur­ity News­wire, which is pro­duced in­de­pend­ently by Na­tion­al Journ­al Group un­der con­tract with the Nuc­le­ar Threat Ini­ti­at­ive. NTI is a non­profit, non­par­tis­an group work­ing to re­duce glob­al threats from nuc­le­ar, bio­lo­gic­al, and chem­ic­al weapons.

What We're Following See More »
FBI To Investigate New Clinton Emails
29 minutes ago
TO AIR OCT. 31 & NOV. 1
Stein, Johnson to Participate in PBS Candidate Forum
51 minutes ago

It was announced on Friday that Gary Johnson and Jill Stein will participate in a candidate's forum, to be filmed live on Oct. 31 and air in two parts. The forum will air on PBS's Tavis Smiley. Additionally, there will be a 30 minute discussion available exclusively online with questions selected from social media.

Obama: Michelle Will Never Run for Office
2 hours ago
North Dakota Pipeline Protests Turn Violent
3 hours ago

The protest over the construction of the Dakota Access Pipeline turned violent overnight as the police and National Guard sought to remove the protesters, surrounding them with assault vehicles and officers in riot gear. The law enforcement officers used pepper spray and fired bean bags for more than six hours. In response, the protesters "lit debris on fire and threw Molotov cocktails in retreat." One woman pulled out a gun and fired at officers, narrowly missing before being arrested. The protesters claim the pipeline would be constructed on land belonging to the Standing Rock Sioux Tribe.

House Leadership Elections Slated for Nov. 15
4 hours ago

The House has scheduled leadership votes for Nov. 15, the day after members return from their election recess. "Since mid-September, members of the House Freedom Caucus have weighed whether they should ask leadership to push back the elections so they can see how House Speaker Paul Ryan performs at the end of the year," but leaders don't seem inclined to grant their request.


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.